In contrast, YAP/TEAD binds to the enhancer region of PD-L1 in human non-small cell lung cancer (NSCLC) [115], human malignant pleural mesothelioma [116], and BRAF inhibitor-resistant melanoma cells [117]. The gene discussed is BRAF; the disease is non-small cell lung carcinoma.